Abbott is recalling the Ellipse Implantable Cardioverter Defibrillators (ICDs) because electrical failures have been identified and determined to be due to a faulty manufacturing process, causing some aluminum wires to be partially exposed. ICDs which contain aluminum wires that are not fully insulated are prone to electrical shorting of the capacitor. The potential patient impact could be the inability to deliver high voltage therapy. There is currently no available method or procedure to determine which of these devices have this issue prior to failure.
Leads Implantable Devices
News and new technology innovations for leads implantable devices can be found on this channel.
July 3, 2023 — Nearly one-third of patients with an implanted device to prevent sudden death have anxiety in the first ...
February 24, 2023 — Biotronik announced that it has received CE approval for the Selectra 3D implant tools to include ...
January 3, 2023 — The market has been studied for the below mentioned-segmentation and regional analysis for North ...
November 22, 2022 — CroíValve has announced the successful First in Human implants of its DUO Tricuspid Coaptation Valve ...
November 2, 2022 — For decades, left ventricular-assist devices (LVADs) have extended the lives of people whose hearts ...
August 5, 2022 — Black people and women with severe heart failure who might be good candidates for surgery to implant a ...

The current standard of care for heart failure (HF) is guideline-directed medical therapy combined with device-based ...
June 16, 2020 - Biotronik has today announced its commitment to giving physicians additional tools to pace in the His ...
September 20, 2019 — BioTrace Medical Inc. announced the company’s key activities at the 31st annual Transcatheter ...
August 5, 2019 — Abbott is recalling the Ellipse Implantable Cardioverter Defibrillators (ICDs) because electrical ...
May 13, 2019 — BioTrace Medical Inc. announced the company’s Tempo Lead has obtained CE Mark certification in Europe for ...
May 6, 2019 — Medtronic has received U.S. Food and Drug Administration (FDA) approval for the Attain Stability Quad MRI ...
This is a virtual heart with the same electrophysiology characteristics as the real patient being developed to help ...

Interventional cardiac resynchronization therapy (I-CRT) describes the repurposing of a set of tools and techniques ...

To extract or abandon broken or infected implantable, venous electrophysiology (EP) device leads has been a debate for ...